Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis

Naoki Ando, Shinji Fujimoto, Tatsuya Ishikawa, Satoru Kobayashi, Ayako Hattori, Tetsuya Ito, Hajime Togari

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Vigabatrin (VGB) is one of the most effective anti-epileptic drugs for tonic spasms, those accompanied with tuberous sclerosis complex (TSC), but is not available in Japan. We treated 7 patients with West syndrome (WS) and TSC with VGB. In these patients, VGB treatment was started at 5-65 months of age. Six patients (86%) had complete cessation of tonic spasms. Of these, 3 patients had complete cessation within 24 hours after VGB treatment. The mean initial dosage of VGB was 36.2 mg·kg-1·day-1, and the mean maintenance dosage was 38.4 mg·kg-1·day -1. At the beginning of VGB treatment, 3 patients had hypsarrhythmia, 2 had focal discharge with generahzation, and 2 had only focal discharge on electroencephalography. Hypsarrhythmia disappeared within 4-8 weeks after VGB treatment. Behavioral problems and sleep difficulty were observed in 6 patients. Visual field examination revealed no abnormalities in 3 patients. We hope that patients with WS and TSC can be treated with VGB as soon as possible in Japan.

Original languageEnglish
Pages (from-to)444-448
Number of pages5
JournalNo To Hattatsu
Volume42
Issue number6
Publication statusPublished - 01-12-2010

Fingerprint

Vigabatrin
Infantile Spasms
Tuberous Sclerosis
Spasm
Japan
Therapeutics
Visual Fields
Electroencephalography
Sleep
Maintenance

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Ando, N., Fujimoto, S., Ishikawa, T., Kobayashi, S., Hattori, A., Ito, T., & Togari, H. (2010). Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis. No To Hattatsu, 42(6), 444-448.
Ando, Naoki ; Fujimoto, Shinji ; Ishikawa, Tatsuya ; Kobayashi, Satoru ; Hattori, Ayako ; Ito, Tetsuya ; Togari, Hajime. / Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis. In: No To Hattatsu. 2010 ; Vol. 42, No. 6. pp. 444-448.
@article{d5c5513648194623991541a1b14ae29e,
title = "Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis",
abstract = "Vigabatrin (VGB) is one of the most effective anti-epileptic drugs for tonic spasms, those accompanied with tuberous sclerosis complex (TSC), but is not available in Japan. We treated 7 patients with West syndrome (WS) and TSC with VGB. In these patients, VGB treatment was started at 5-65 months of age. Six patients (86{\%}) had complete cessation of tonic spasms. Of these, 3 patients had complete cessation within 24 hours after VGB treatment. The mean initial dosage of VGB was 36.2 mg·kg-1·day-1, and the mean maintenance dosage was 38.4 mg·kg-1·day -1. At the beginning of VGB treatment, 3 patients had hypsarrhythmia, 2 had focal discharge with generahzation, and 2 had only focal discharge on electroencephalography. Hypsarrhythmia disappeared within 4-8 weeks after VGB treatment. Behavioral problems and sleep difficulty were observed in 6 patients. Visual field examination revealed no abnormalities in 3 patients. We hope that patients with WS and TSC can be treated with VGB as soon as possible in Japan.",
author = "Naoki Ando and Shinji Fujimoto and Tatsuya Ishikawa and Satoru Kobayashi and Ayako Hattori and Tetsuya Ito and Hajime Togari",
year = "2010",
month = "12",
day = "1",
language = "English",
volume = "42",
pages = "444--448",
journal = "No To Hattatsu",
issn = "0029-0831",
publisher = "Japanese Society of Child Neurology",
number = "6",

}

Ando, N, Fujimoto, S, Ishikawa, T, Kobayashi, S, Hattori, A, Ito, T & Togari, H 2010, 'Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis', No To Hattatsu, vol. 42, no. 6, pp. 444-448.

Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis. / Ando, Naoki; Fujimoto, Shinji; Ishikawa, Tatsuya; Kobayashi, Satoru; Hattori, Ayako; Ito, Tetsuya; Togari, Hajime.

In: No To Hattatsu, Vol. 42, No. 6, 01.12.2010, p. 444-448.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis

AU - Ando, Naoki

AU - Fujimoto, Shinji

AU - Ishikawa, Tatsuya

AU - Kobayashi, Satoru

AU - Hattori, Ayako

AU - Ito, Tetsuya

AU - Togari, Hajime

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Vigabatrin (VGB) is one of the most effective anti-epileptic drugs for tonic spasms, those accompanied with tuberous sclerosis complex (TSC), but is not available in Japan. We treated 7 patients with West syndrome (WS) and TSC with VGB. In these patients, VGB treatment was started at 5-65 months of age. Six patients (86%) had complete cessation of tonic spasms. Of these, 3 patients had complete cessation within 24 hours after VGB treatment. The mean initial dosage of VGB was 36.2 mg·kg-1·day-1, and the mean maintenance dosage was 38.4 mg·kg-1·day -1. At the beginning of VGB treatment, 3 patients had hypsarrhythmia, 2 had focal discharge with generahzation, and 2 had only focal discharge on electroencephalography. Hypsarrhythmia disappeared within 4-8 weeks after VGB treatment. Behavioral problems and sleep difficulty were observed in 6 patients. Visual field examination revealed no abnormalities in 3 patients. We hope that patients with WS and TSC can be treated with VGB as soon as possible in Japan.

AB - Vigabatrin (VGB) is one of the most effective anti-epileptic drugs for tonic spasms, those accompanied with tuberous sclerosis complex (TSC), but is not available in Japan. We treated 7 patients with West syndrome (WS) and TSC with VGB. In these patients, VGB treatment was started at 5-65 months of age. Six patients (86%) had complete cessation of tonic spasms. Of these, 3 patients had complete cessation within 24 hours after VGB treatment. The mean initial dosage of VGB was 36.2 mg·kg-1·day-1, and the mean maintenance dosage was 38.4 mg·kg-1·day -1. At the beginning of VGB treatment, 3 patients had hypsarrhythmia, 2 had focal discharge with generahzation, and 2 had only focal discharge on electroencephalography. Hypsarrhythmia disappeared within 4-8 weeks after VGB treatment. Behavioral problems and sleep difficulty were observed in 6 patients. Visual field examination revealed no abnormalities in 3 patients. We hope that patients with WS and TSC can be treated with VGB as soon as possible in Japan.

UR - http://www.scopus.com/inward/record.url?scp=78649430308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649430308&partnerID=8YFLogxK

M3 - Article

C2 - 21077355

AN - SCOPUS:78649430308

VL - 42

SP - 444

EP - 448

JO - No To Hattatsu

JF - No To Hattatsu

SN - 0029-0831

IS - 6

ER -

Ando N, Fujimoto S, Ishikawa T, Kobayashi S, Hattori A, Ito T et al. Effectiveness of vigabatrin in West syndrome associated with tuberous sclerosis. No To Hattatsu. 2010 Dec 1;42(6):444-448.